Cost–effectiveness of supplementing a broth-enriched culture test with the Xpert meticillin-resistant Staphylococcus aureus (MRSA) assay for screening inpatients at high risk of MRSA

Summary Background Meticillin-resistant Staphylococcus aureus (MRSA) represents a considerable challenge for health care in terms of complications and costs. Whilst bacteriological culture remains the most common method for detecting MRSA, the polymerase-chain-reaction-based Xpert MRSA assay was int...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of hospital infection 2012-12, Vol.82 (4), p.227-233
Hauptverfasser:	Li, J, Ulvin, K, Biboh, H, Kristiansen, I.S
Format:	Artikel
Sprache:	eng
Schlagworte:	Assays Bacterial diseases Bacteriological Techniques - economics Bacteriological Techniques - methods Biological and medical sciences Carrier State - diagnosis Complications Cost benefit analysis Cost-effectiveness Daytime Drug resistance Epidemiological Monitoring Health care Hospitals Human bacterial diseases Humans Infectious Disease Infectious diseases Inpatients Mass Screening - economics Mass Screening - methods Medical sciences Methicillin-Resistant Staphylococcus aureus - genetics Methicillin-Resistant Staphylococcus aureus - growth & development Methicillin-Resistant Staphylococcus aureus - isolation & purification Meticillin-resistant Staphylococcus aureus Molecular Diagnostic Techniques - economics Molecular Diagnostic Techniques - methods Norway Quality of life Rapid test Risk factors Screening Staphylococcal Infections - diagnosis Staphylococcal infections, streptococcal infections, pneumococcal infections Staphylococcus aureus Xpert
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!